GETINGE, Sweden--(BUSINESS WIRE)--Regulatory News: The Board of Getinge AB (STO:GETIB) is today announcing the appointment of Mattias Perjos as President and CEO of Getinge. Mattias currently holds ...

STOCKHOLM, Dec. 13, 2010 /PRNewswire/ -- When Getinge Group needed to enhance its global communication environment, it turned to Verizon Business. Under a new 3 1/2-year agreement, Verizon will deploy ...

GETINGE, Sweden--(BUSINESS WIRE)--Regulatory News: Getinge Group (STO:GETIB) has appointed Pernille Fabricius as new Chief Financial Officer of Getinge Group. Pernille will be part of the Getinge ...

GETINGE, Sweden--(BUSINESS WIRE)-- Regulatory News: GETINGE (STO:GETIB) will issue its Q4 report for 2010 on Wednesday 26th January 2011 at 12:00 CET, followed by a conference call at 15.00 CET, ...

Getinge Group, a leading global provider of innovative medical technology, announce today its continuous commitment to Arab Health, the largest healthcare exhibition and educational platform in the ...

WAYNE, N.J., Getinge Group today announced the launch of a new, highly flexible angiography solution for surgery, interventional and Hybrid operating room (OR) procedures in the United States. Jointly ...

Getinge, a leading global provider of innovative medical technology, announce today its sponsorship and support of two important scientific symposia at ISICEM. Getinge will also launch, for the first ...

January 17, 2017 — Wayne, N.J. – Getinge Group, a leading global provider of products and systems that contribute to quality enhancement and cost efficiency within healthcare and life sciences, ...

Getinge GroupJohan MalmquistCEO,Telephone: +46 10 335 55 33E-mail: orUlf GrunanderCFO,Telephone: +46 10 335 55 80E-mail: orExtended CareAlex MyersCEO,Telephone: +46 10 335 46 53E-mail: Getinge has ...

Getinge Group has launched a “highly flexible” angiography product which was developed along with GE Healthcare ($GE). The product is for use during surgery ...

STOCKHOLM, Feb 1 (Reuters) - Swedish medical gear group Getinge (GETIb.ST), opens new tab reported an unexpected slide in quarterly profit on Wednesday as supply disruptions continued and ...

Gesynta Pharma AB today announced that the first patient has been dosed in its Phase 2 clinical proof-of-concept trial (NOVA) of vipoglanstat, a novel ...